tyrosine has been researched along with Acute Relapsing Multiple Sclerosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hooper, DC; Jacobs, D; Koprowski, H; Markowitz, CE; Spitsin, S; Udupa, JK; Zimmerman, V | 1 |
Majsterek, I; Miller, E; Ponczek, MB; Saluk, J; Walczak, A | 1 |
Basic, J; Cvetkovic, T; Ilic, A; Ljubisavljevic, S; Pavlovic, D; Pavlovic, R; Stojanovic, I; Stukalov, M; Vojinovic, S | 1 |
Felaco, M; Gambi, D; Iarlori, C; Lugaresi, A; Patruno, A; Reale, M; Salvatore, M; Speranza, L | 1 |
2 trial(s) available for tyrosine and Acute Relapsing Multiple Sclerosis
Article | Year |
---|---|
The treatment of multiple sclerosis with inosine.
Topics: Adjuvants, Immunologic; Administration, Oral; Adult; Brain; CD4 Lymphocyte Count; Central Nervous System; Cross-Over Studies; Cytokines; Disability Evaluation; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Inosine; Kidney Calculi; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Th1 Cells; Th2 Cells; Tyrosine; Uric Acid; Young Adult | 2009 |
Reduction of free radicals in multiple sclerosis: effect of glatiramer acetate (Copaxone).
Topics: Adult; Cells, Cultured; Female; Free Radicals; Glatiramer Acetate; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Peptides; Superoxides; Tyrosine | 2008 |
2 other study(ies) available for tyrosine and Acute Relapsing Multiple Sclerosis
Article | Year |
---|---|
Oxidative modification of patient's plasma proteins and its role in pathogenesis of multiple sclerosis.
Topics: Adult; Blood Proteins; Blood-Brain Barrier; Carbon; Disease Progression; Female; Humans; Male; Middle Aged; Models, Statistical; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Oxidative Stress; Oxygen; Reactive Oxygen Species; Tyrosine; Uric Acid | 2012 |
INF-β1b therapy modulates L-arginine and nitric oxide metabolism in patients with relapse remittent multiple sclerosis.
Topics: Adult; Arginase; Arginine; Biomarkers; Drug Monitoring; Female; Follow-Up Studies; Humans; Inflammation; Interferon beta-1b; Interferon-beta; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Nitrates; Nitric Oxide; Nitrites; Nitroso Compounds; Severity of Illness Index; Sulfhydryl Compounds; Tyrosine; Young Adult | 2012 |